All the news Showing 10 of 819 articles from: Health services, policy and advocacyGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Only 11 countries on target to eliminate hepatitis C by 2030 Keith Alcorn / 15 November 2022 Only 11 countries are on course to meet their goals for elimination of hepatitis C by 2030, while five countries with the highest burdens of hepatitis C are unlikely to achieve elimination ... UK close to elimination of hepatitis C among people with HIV Keith Alcorn / 06 October 2022 The United Kingdom is close to eliminating hepatitis C as an infection among people with HIV, according to an audit of HIV services carried out in 2021, published in the journal HIV ... Peer-led recruitment improves hepatitis C screening in people who use drugs Keith Alcorn / 25 July 2022 A peer-led recruitment strategy proved highly successful in engaging people who use drugs in testing and treatment for hepatitis C in the French city of Montpellier, researchers from the University of Montpellier report ... Test-and-treat leads to sustained fall in hepatitis C in Swiss gay men with HIV Keith Alcorn / 18 April 2022 Intensive screening for hepatitis C, treatment and risk reduction counselling have led to sustained declines in hepatitis C prevalence and new cases of hepatitis C among gay and bisexual men living with ... Vaccine “Unaffordable” in Hepatitis B Endemic Liberia Front Page Africa / 09 March 2022 Decline in hepatitis C infections globally is encouraging but still not enough Center for Disease Analysis press release / 09 March 2022 Hepatitis C treatment and cure targets for people living with HIV still not being met in Europe Alain Volny-Anne / 22 February 2022 While over 90% of people living with HIV in Europe have been tested for hepatitis C, diagnosis remains suboptimal in the east of the continent. In three of five European ... The EASL–Lancet Liver Commission calls for a paradigm shift in the liver disease response in Europe EASL / 13 December 2021 Treatment for hepatitis B and C fell in 2020 due to COVID-19, global survey finds Keith Alcorn / 16 November 2021 Viral hepatitis tests and treatment declined significantly during 2020 as a consequence of the COVID-19 pandemic, a survey of 31 liver centres on five continents has shown. The decline in testing and ... Hepatitis C elimination: less than 25% of people with hepatitis C diagnosed globally Keith Alcorn / 15 November 2021 The global prevalence of hepatitis C has declined since 2015, partly due to scale-up of direct-acting antiviral treatment, but fewer than one in four people with hepatitis C has been diagnosed, ... ← First12345...82Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Access to medicines & diagnostics Hepatitis C elimination Models of care Finance, funding & health economics National policy European policy International policy Activism and civil society Pharmaceutical industry Social issues Conference news Email bulletin archive